Hangzhou Yirui Pharmaceutical Technology Co., Ltd.
π¨π³China
- Country
- π¨π³China
- Ownership
- Private, Subsidiary
- Established
- 2018-06-12
- Employees
- -
- Market Cap
- -
- Website
- http://yirui-pharma.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-05-29
- Target Recruit Count
- 36
- Registration Number
- NCT06309355
- Locations
- πΊπΈ
Encore Medical Research -Boynton Beach, Boynton Beach, Florida, United States
πΊπΈEncore Medical Research-Hollywood, Hollywood, Florida, United States
πΊπΈEncore Medical Research-Weston, Weston, Florida, United States
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
Phase 1
Completed
- Conditions
- PsoriasisAtopic Dermatitis
- Interventions
- Drug: YR001 Dose A on low body surface areaDrug: YR001 Dose B on middle body surface areaDrug: YR001 Dose A on high body surface areaDrug: YR001 Dose B on low body surface areaDrug: YR001 Dose B on high body surface areaDrug: Placebo on low body surface areaDrug: Placebo on high body surface areaDrug: YR001 Dose A on high body surface area twice dailyDrug: Placebo on high body surface area twice dailyDrug: YR001 Dose A on middle body surface areaDrug: YR001 Dose B on high body surface area twice dailyDrug: Placebo on middle body surface area
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-01-24
- Target Recruit Count
- 54
- Registration Number
- NCT05718921
- Locations
- πΊπΈ
California Dermatology & Clinical Research Institute, Encinitas, California, United States
News
No news found